The five-year grant from the Cancer Prevention and Research Institute of Texas will support infrastructure to investigate and advance cancer prevention and care.
Preliminary data indicate that the compounds developed in the laboratory of Dr. Stephen Safe both kill tumors and rejuvenate the immune system, which becomes exhausted as it responds to cancer.
A Texas A&M team is developing an intracavity device that will allow doctors to eliminate leftover cancer cells during surgery, reducing the need for additional treatments such as chemotherapy.
Texas A&M chemist Jonathan Sczepanski has won two National Science Foundation grants to examine different aspects of DNA, including forms that cause cancer.